$DMNIF

Damon Inc.

CIK:0002000640|SEC Filings

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Income Statement [Abstract]
Revenue	$ 80,691
Cost of revenue	40,345
Gross profit	40,346
Operating expenses
Research and development, net	1,109,302	57,221
General and administrative	1,689,370	790,027
Sales and marketing	130,966	174,166
Transaction costs		748,541
Depreciation	16,155	67,248
Foreign currency transaction (gain) / loss	(79,436)	62,738
Operating income (expenses)	2,866,357	1,899,941
Loss from operations	(2,826,011)	(1,899,941)
Other expenses
Changes in fair value of financial liabilities		(4,657,388)
Finance expense	(476,448)	(854,846)
Non operating income (expenses)	(476,448)	(5,512,234)
Loss before income taxes	(3,302,459)	(7,412,175)
Current income tax expense
Net loss	(3,302,459)	(7,412,175)
COMPREHENSIVE LOSS
Net loss	(3,302,459)	(7,412,175)
Other comprehensive loss
Foreign currency translation adjustments	4,299
Comprehensive loss	$ (3,298,160)	$ (7,412,175)
Loss per common share – basic (in Dollars per share)	$ (0.17)	$ (320)
Loss per common share – diluted (in Dollars per share)	$ (0.17)	$ (320)
Weighted average number of common shares outstanding – basic (in Shares)	19,603,815	23,152
Weighted average number of common shares outstanding – diluted (in Shares)	19,603,815	23,152

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Operating activities
Net loss	$ (3,302,459)	$ (7,412,175)
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation	16,155	67,248
Stock-based compensation	9,836	16,295
Non-cash interest	499,174	809,520
Changes in fair value of financial liabilities		4,657,388
Foreign exchange (gain) / loss	(7,129)	20,309
Changes in operating assets and liabilities:
Other current assets and premises lease deposits	440,643	(25,763)
Accounts receivable	(58,392)
Funding receivable		(1,004,022)
Accounts payable and accrued liabilities	623,207	733,170
Deferred revenue	33,381
Operating lease	(3,602)	(16,370)
Customer deposits	(9,873)	(6,171)
Cash used in operating activities	(1,759,059)	(2,160,571)
Financing activities
Payments on finance leases	(1,821)	(1,759)
Proceeds from promissory notes		729,299
Repayment of short-term debt	(35,000)
Proceeds from convertible notes		555,000
Proceeds from senior secured promissory notes		596,000
Cash (used in) / provided by financing activities	(36,821)	1,878,540
Effect of exchange rates on cash holdings in foreign currencies	(1,577)
Net change in cash and restricted cash during the period	(1,797,457)	(282,031)
Cash and restricted cash at beginning of period	2,522,656	395,580
Cash and restricted cash at end of period	725,199	113,549
Supplemental disclosure of cash flow information:
Interest on finance lease paid	2,122	2,240
Supplemental disclosure of non-cash investing and financing activity:
SAFEs converted to common shares		$ 3,200,000

Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2025	Jun. 30, 2025
Current assets
Cash	$ 682,232	$ 2,479,283
Accounts receivable, net of allowance	80,523	22,131
Other current assets	406,110	846,748
Current assets	1,168,865	3,348,162
Non-current assets
Restricted cash	42,967	43,373
Premises lease deposits	133,527	133,532
Property and equipment, net	65,705	81,892
Operating lease right-of-use assets, net	404,827	475,739
Non-current assets	647,026	734,536
Total assets	1,815,891	4,082,698
Current liabilities
Accounts payable and accrued liabilities	5,314,287	4,691,080
Customer deposits	434,885	444,759
Deferred revenue	237,612	204,231
Current portion of operating lease liabilities	229,624	294,475
Current portion of finance lease liabilities	172,693	178,447
Short-term debt	477,519	504,685
Pre-paid security purchase, net of debt discount	3,030,465	2,962,518
Convertible promissory note, net of debt discount	4,977,327	4,553,934
Current liabilities	14,874,412	13,834,129
Non-current liabilities
Non-current portion of operating lease liabilities	117,888	136,654
Non-current liabilities	117,888	136,654
Total liabilities	14,992,300	13,970,783
Commitment and contingencies (Note 14)
STOCKHOLDERS’ DEFICIT
Common shares without par value, unlimited shares authorized, 19,603,815 shares issued and outstanding as of September 30, 2025 (June 30, 2025 – 19,603,815)	118,513,491	118,513,491
Additional paid in capital	17,578,114	17,568,278
Accumulated other comprehensive loss	(7,299)	(11,598)
Accumulated deficit	(149,260,715)	(145,958,256)
Total stockholders’ deficit	(13,176,409)	(9,888,085)
Total liabilities and stockholders’ deficit	$ 1,815,891	$ 4,082,698